MetLife Investment Management, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,393,382
+1.9%
141,188
-3.8%
0.04%
+7.5%
Q2 2023$5,294,751
-7.5%
146,791
-2.1%
0.04%
-4.8%
Q1 2023$5,723,611
-33.9%
149,872
-1.5%
0.04%
-39.1%
Q4 2022$8,654,319
+38.7%
152,097
-3.6%
0.07%
+27.8%
Q3 2022$6,238,898
-9.8%
157,787
+0.3%
0.05%
-5.3%
Q2 2022$6,919,880
+6.8%
157,270
-3.2%
0.06%
+32.6%
Q1 2022$6,477,070
+38.9%
162,414
+40.1%
0.04%
+10.3%
Q4 2021$4,662,591
-3.3%
115,956
-2.2%
0.04%
-13.3%
Q3 2021$4,823,061
-9.3%
118,561
+1.3%
0.04%
-10.0%
Q2 2021$5,315,695
+10.0%
117,060
+1.0%
0.05%
+8.7%
Q1 2021$4,830,412
-7.8%
115,865
-5.5%
0.05%
-13.2%
Q4 2020$5,239,150
+232.8%
122,668
+104.8%
0.05%
+211.8%
Q3 2020$1,574,409
-2.0%
59,9090.0%0.02%
-5.6%
Q2 2020$1,606,160
+55.8%
59,909
+4.6%
0.02%
+20.0%
Q1 2020$1,030,773
-9.9%
57,297
-11.2%
0.02%
+25.0%
Q4 2019$1,143,638
+14.3%
64,5030.0%0.01%
+9.1%
Q3 2019$1,000,442
-9.7%
64,5030.0%0.01%
-8.3%
Q2 2019$1,108,159
+23.5%
64,503
+15.7%
0.01%
+20.0%
Q1 2019$897,301
+10.0%
55,7330.0%0.01%0.0%
Q4 2018$815,374
-19.5%
55,7330.0%0.01%
-9.1%
Q3 2018$1,012,669
+7.7%
55,7330.0%0.01%0.0%
Q2 2018$940,000
-13.9%
55,7330.0%0.01%
-15.4%
Q1 2018$1,092,000
-3.3%
55,7330.0%0.01%0.0%
Q4 2017$1,129,00055,7330.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders